NMTC

Neuroone Medical Technologies
$1.76
−$0.14 (−7.37%)Jul 27, 2026
1.8PoorMoatMint rating

MoatMint rates Neuroone Medical Technologies (NMTC) 1.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.9 out of 10.

Key metrics

The numbers that frame NMTC today
Market cap
$15.32M
P/E (TTM)
-2.2
EV / FCF
-1.7
Gross margin
54.4%
EV / Sales
1.4
ROIC
-258.3%
Div yield
0%
Debt / equity
0.0
52wk Low
$1.71
52wk High
$6.96

NMTC stock rating

How NMTC scores on quality, value, growth, momentum and financial health
1.8out of 10
Low overallFair business, expensive priceTop 82% of ~5,000 US stocks
QualityPoor1.9/10
GrowthGreat9.7/10
MomentumPoor1.8/10
ValuePoor1.3/10
Financial HealthFair2.0/10

Growth

Revenue and earnings trend for NMTC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about NMTC
Is Neuroone Medical Technologies a good buy?
No. Neuroone Medical Technologies has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Neuroone Medical Technologies is selling at a very high price.
What is the market capitalization of NMTC?
Neuroone Medical Technologies's market capitalization is $15.32M.
What is the P/E ratio for NMTC stock?
Neuroone Medical Technologies's current P/E ratio is -2.2.
What is the 52-week high for NMTC stock?
The 52-week high for Neuroone Medical Technologies is $6.96. The current close of $1.76 is 74.7% below that high.
What is the 52-week low for NMTC stock?
The 52-week low for Neuroone Medical Technologies is $1.71. The current close of $1.76 is 2.9% above that low.
Does NMTC stock pay dividends?
Neuroone Medical Technologies does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NMTC?
Neuroone Medical Technologies's Debt / Equity ratio is 0.02.